Logo image of FEMY

FEMASYS INC (FEMY) Stock Fundamental Analysis

USA - NASDAQ:FEMY - US31447E1055 - Common Stock

0.3539 USD
+0.01 (+2.58%)
Last: 9/26/2025, 2:52:10 PM
Fundamental Rating

2

FEMY gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 190 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of FEMY have multiple concerns. FEMY is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year FEMY has reported negative net income.
In the past year FEMY has reported a negative cash flow from operations.
In the past 5 years FEMY always reported negative net income.
FEMY had a negative operating cash flow in each of the past 5 years.
FEMY Yearly Net Income VS EBIT VS OCF VS FCFFEMY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

The Return On Assets of FEMY (-152.50%) is worse than 88.42% of its industry peers.
FEMY has a Return On Equity of -1394.14%. This is amonst the worse of the industry: FEMY underperforms 89.47% of its industry peers.
Industry RankSector Rank
ROA -152.5%
ROE -1394.14%
ROIC N/A
ROA(3y)-89.97%
ROA(5y)-77.42%
ROE(3y)-322.97%
ROE(5y)-238.66%
ROIC(3y)N/A
ROIC(5y)N/A
FEMY Yearly ROA, ROE, ROICFEMY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800

1.3 Margins

With a decent Gross Margin value of 65.09%, FEMY is doing good in the industry, outperforming 68.95% of the companies in the same industry.
In the last couple of years the Gross Margin of FEMY has declined.
FEMY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y-2.71%
FEMY Yearly Profit, Operating, Gross MarginsFEMY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -500 -1K

More info and screens

0

2. Health

2.1 Basic Checks

FEMY does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for FEMY has been increased compared to 1 year ago.
FEMY has more shares outstanding than it did 5 years ago.
The debt/assets ratio for FEMY is higher compared to a year ago.
FEMY Yearly Shares OutstandingFEMY Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
FEMY Yearly Total Debt VS Total AssetsFEMY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

Based on the Altman-Z score of -17.63, we must say that FEMY is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -17.63, FEMY is not doing good in the industry: 87.37% of the companies in the same industry are doing better.
A Debt/Equity ratio of 4.03 is on the high side and indicates that FEMY has dependencies on debt financing.
The Debt to Equity ratio of FEMY (4.03) is worse than 87.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.03
Debt/FCF N/A
Altman-Z -17.63
ROIC/WACCN/A
WACC6.67%
FEMY Yearly LT Debt VS Equity VS FCFFEMY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

FEMY has a Current Ratio of 0.89. This is a bad value and indicates that FEMY is not financially healthy enough and could expect problems in meeting its short term obligations.
FEMY's Current ratio of 0.89 is on the low side compared to the rest of the industry. FEMY is outperformed by 90.53% of its industry peers.
FEMY has a Quick Ratio of 0.89. This is a bad value and indicates that FEMY is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.41, FEMY is doing worse than 92.11% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.89
Quick Ratio 0.41
FEMY Yearly Current Assets VS Current LiabilitesFEMY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for FEMY have decreased by -2.41% in the last year.
FEMY shows a strong growth in Revenue. In the last year, the Revenue has grown by 98.62%.
The Revenue has been growing by 11.86% on average over the past years. This is quite good.
EPS 1Y (TTM)-2.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.57%
Revenue 1Y (TTM)98.62%
Revenue growth 3Y11.35%
Revenue growth 5Y11.86%
Sales Q2Q%112.22%

3.2 Future

Based on estimates for the next years, FEMY will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.02% on average per year.
The Revenue is expected to grow by 109.73% on average over the next years. This is a very strong growth
EPS Next Y29.2%
EPS Next 2Y22.8%
EPS Next 3Y14.67%
EPS Next 5Y13.02%
Revenue Next Year21.15%
Revenue Next 2Y73.38%
Revenue Next 3Y126.15%
Revenue Next 5Y109.73%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
FEMY Yearly Revenue VS EstimatesFEMY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
FEMY Yearly EPS VS EstimatesFEMY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

FEMY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for FEMY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FEMY Price Earnings VS Forward Price EarningsFEMY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FEMY Per share dataFEMY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

FEMY's earnings are expected to grow with 14.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.8%
EPS Next 3Y14.67%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for FEMY!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FEMASYS INC

NASDAQ:FEMY (9/26/2025, 2:52:10 PM)

0.3539

+0.01 (+2.58%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-08 2025-08-08/amc
Earnings (Next)11-10 2025-11-10
Inst Owners12%
Inst Owner Change30.09%
Ins Owners10.52%
Ins Owner Change9.52%
Market Cap15.22M
Analysts82
Price Target6.38 (1702.77%)
Short Float %2.41%
Short Ratio0.98
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.19%
Min EPS beat(2)-18.68%
Max EPS beat(2)18.3%
EPS beat(4)1
Avg EPS beat(4)-9.98%
Min EPS beat(4)-21.89%
Max EPS beat(4)18.3%
EPS beat(8)3
Avg EPS beat(8)-5.92%
EPS beat(12)5
Avg EPS beat(12)-4.03%
EPS beat(16)7
Avg EPS beat(16)-0.14%
Revenue beat(2)0
Avg Revenue beat(2)-62.91%
Min Revenue beat(2)-70.71%
Max Revenue beat(2)-55.12%
Revenue beat(4)0
Avg Revenue beat(4)-51.94%
Min Revenue beat(4)-70.71%
Max Revenue beat(4)-16.58%
Revenue beat(8)0
Avg Revenue beat(8)-46.57%
Revenue beat(12)1
Avg Revenue beat(12)-34.57%
Revenue beat(16)3
Avg Revenue beat(16)-25.25%
PT rev (1m)-13.79%
PT rev (3m)-13.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)10.71%
EPS NY rev (1m)0%
EPS NY rev (3m)7.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-21.57%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-38.66%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.07
P/FCF N/A
P/OCF N/A
P/B 10.1
P/tB 10.48
EV/EBITDA N/A
EPS(TTM)-0.85
EYN/A
EPS(NY)-0.42
Fwd EYN/A
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)-0.46
OCFYN/A
SpS0.04
BVpS0.04
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -152.5%
ROE -1394.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.09%
FCFM N/A
ROA(3y)-89.97%
ROA(5y)-77.42%
ROE(3y)-322.97%
ROE(5y)-238.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y-2.71%
F-Score3
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 4.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 85.95%
Cap/Sales 39.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.89
Quick Ratio 0.41
Altman-Z -17.63
F-Score3
WACC6.67%
ROIC/WACCN/A
Cap/Depr(3y)62.1%
Cap/Depr(5y)48.65%
Cap/Sales(3y)33.12%
Cap/Sales(5y)25.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.57%
EPS Next Y29.2%
EPS Next 2Y22.8%
EPS Next 3Y14.67%
EPS Next 5Y13.02%
Revenue 1Y (TTM)98.62%
Revenue growth 3Y11.35%
Revenue growth 5Y11.86%
Sales Q2Q%112.22%
Revenue Next Year21.15%
Revenue Next 2Y73.38%
Revenue Next 3Y126.15%
Revenue Next 5Y109.73%
EBIT growth 1Y-16.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-82.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-78.96%
OCF growth 3YN/A
OCF growth 5YN/A